Literature DB >> 16353910

Drug compounding for veterinary patients.

Mark G Papich1.   

Abstract

Drugs have been compounded for veterinary practice for many years because it has been necessary in the course of routine practice. However, regulations and compliance policy guidelines (CPGs) should be recognized. A new CPG issued in July 2003 listed the current Food and Drug Administration (FDA) limitations on compounding for veterinary medicine. To summarize the guideline: drugs must not be compounded from bulk substances, and the compounding must not constitute manufacture of a new animal drug. Drug compounding on a case-by-case basis is allowed under the CPG. However, veterinarians and pharmacists must be aware of potential incompatibilities and practices that may interfere with the drug's stability, purity, and/or potency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16353910      PMCID: PMC2750966          DOI: 10.1208/aapsj070229

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  27 in total

1.  Esophageal transit of capsules in clinically normal cats.

Authors:  J P Graham; A H Lipman; S M Newell; G D Roberts
Journal:  Am J Vet Res       Date:  2000-06       Impact factor: 1.156

Review 2.  Potential and problems of developing transdermal patches for veterinary applications.

Authors:  J E Riviere; M G Papich
Journal:  Adv Drug Deliv Rev       Date:  2001-09-01       Impact factor: 15.470

3.  Systemic absorption of amitriptyline and buspirone after oral and transdermal administration to healthy cats.

Authors:  K L Mealey; K E Peck; B S Bennett; R K Sellon; G R Swinney; K Melzer; S A Gokhale; T M Krone
Journal:  J Vet Intern Med       Date:  2004 Jan-Feb       Impact factor: 3.333

Review 4.  Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part II. Physiological considerations.

Authors:  Marilyn Martinez; Gordon Amidon; Lane Clarke; Wendelyn Warren Jones; Ashim Mitra; Jim Riviere
Journal:  Adv Drug Deliv Rev       Date:  2002-10-04       Impact factor: 15.470

5.  Compounding for creatures: what works.

Authors:  J Davis
Journal:  Int J Pharm Compd       Date:  1999 May-Jun

6.  FDA/CVM's Compliance Policy Guide on compounding of drugs.

Authors: 
Journal:  J Am Vet Med Assoc       Date:  1996-12-15       Impact factor: 1.936

7.  Compounding in veterinary medicine. Symposium proceedings and task force reports.

Authors: 
Journal:  J Am Vet Med Assoc       Date:  1994-07-15       Impact factor: 1.936

Review 8.  Physiologically-based pharmacokinetic simulation modelling.

Authors:  George M Grass; Patrick J Sinko
Journal:  Adv Drug Deliv Rev       Date:  2002-03-31       Impact factor: 15.470

9.  A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability.

Authors:  G L Amidon; H Lennernäs; V P Shah; J R Crison
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

Review 10.  Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals.

Authors:  T T Kararli
Journal:  Biopharm Drug Dispos       Date:  1995-07       Impact factor: 1.627

View more
  6 in total

1.  The role and education of the veterinary pharmacist.

Authors:  Michelle L Ceresia; Carl E Fasser; John E Rush; Richard T Scheife; Connie J Orcutt; Donald L Michalski; Melissa R Mazan; Mary T Dorsey; Stephen P Bernardi
Journal:  Am J Pharm Educ       Date:  2009-02-19       Impact factor: 2.047

2.  Compounding errors in 2 dogs receiving anticonvulsants.

Authors:  Sandra E McConkey; Susan Walker; Cathy Adams
Journal:  Can Vet J       Date:  2012-04       Impact factor: 1.008

3.  Drug exposure and clinical effect of transdermal mirtazapine in healthy young cats: a pilot study.

Authors:  Kellyi K Benson; Lara B Zajic; Paula K Morgan; Sarah R Brown; Ryan J Hansen; Paul J Lunghofer; Luke A Wittenburg; Daniel L Gustafson; Jessica M Quimby
Journal:  J Feline Med Surg       Date:  2016-09-01       Impact factor: 2.015

Review 4.  Veterinary Compounding: Regulation, Challenges, and Resources.

Authors:  Gigi Davidson
Journal:  Pharmaceutics       Date:  2017-01-10       Impact factor: 6.321

5.  First feline case of otodectosis in the Republic of Korea and successful treatment with imidacloprid/moxidectin topical solution.

Authors:  Ah-Jin Ahn; Dae-Sung Oh; Kyu-Sung Ahn; Sung-Shik Shin
Journal:  Korean J Parasitol       Date:  2013-02-18       Impact factor: 1.341

6.  The use of fluoxetine by veterinarians in dogs and cats: a preliminary survey.

Authors:  Gagandeep Kaur; Victoria L Voith; Peggy L Schmidt
Journal:  Vet Rec Open       Date:  2016-04-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.